The role of intravenous clomipramine in the treatment of obsessional and phobic disorders.
The results of intravenous clomipramine therapy in 118 patients suffering from obsessional syndromes and phobic anxiety states are reviewed. A remarkable consistency of improvement was observed especially in those patients suffering from obsessional symptoms. Better results were obtained in patients lacking hysterical personality traits. A brief reference is made to a pilot study involving the use of the 16PF personality test in assessing the effect of clomipramine.
D000328:Adult; D002997:Clomipramine / Q000008:administration & dosage / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006677:Histrionic Personality Disorder / Q000150:complications; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000150:complications / Q000188:drug therapy*; D010555:Personality Inventory; D010698:Phobic Disorders / Q000188:drug therapy*
D003984:Dibenzazepines; D002997:Clomipramine